Steven Cohen’s Assembly Biosciences ASMB Stock Holding History

Steven Cohen’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.7M	Buy	460,593 +116,488	+34%	+$3.17M	0.01%	1138
2026 Q1	$9.55M	Sell	344,105 -256,504	-43%	-$7.32M	0.01%	1288
2025 Q4	$20.4M	Buy	600,609 +304,592	+103%	+$9.81M	0.02%	873
2025 Q3	$7.58M	Buy	+296,017	New	+$6.49M	0.01%	910
2019 Q2	–	Sell	-8,333	Closed	-$1.97M	–	1328
2019 Q1	$1.97M	Buy	+8,333	New	+$2.11M	0.01%	702
2018 Q4	–	Sell	-913	Closed	-$407K	–	956
2018 Q3	$407K	Buy	+913	New	+$428K	﹤0.01%	939

Other funds holding ASMB

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SFCM

Seven Fleet Capital Management Mountain View, California $606M AUM

Steven Cohen's ASMB Position: Q2 2026 in Review

Steven Cohen increased its Assembly Biosciences (ASMB) stake by 34% in Q2 2026, buying an estimated $3.17M and bringing the position to 460,593 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #1138.

Steven Cohen first reported a position in ASMB in Q3 2018 and has held it in 6 quarters since. The position peaked at $20.4M in Q4 2025. 92 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

Steven Cohen held 460,593 shares of Assembly Biosciences worth $12.7M as of Q2 2026.
Steven Cohen bought 116,488 Assembly Biosciences shares in Q2 2026, an estimated $3.17M.
Assembly Biosciences made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1138 holding.
Steven Cohen first reported a position in Assembly Biosciences in Q3 2018 and has held it in 6 quarters since.
Steven Cohen's Assembly Biosciences position peaked at $20.4M in Q4 2025.
92 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.